Every SEC Form 3/4/5 on record for this filer (CIK 1636738) — 3 issuers, 12 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| CLDI | Calidi Biotherapeutics, Inc. | Chief Financial Officer | 2023-11-02 → 2025-09-05 | 4 | $5,000 |
| BTX | Brooklyn ImmunoTherapeutics, Inc. | Chief Financial Officer · lapsed | 2022-06-01 → 2022-06-06 | 2 | — |
| RMED | Ra Medical Systems, Inc. | CFO · lapsed | 2018-09-26 → 2022-05-24 | 11 | −$14,745 |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| CLDI | 2025-08-21 | Buy | 2,500 | $2.00 | $5,000 | 2,500 |
| RMED | 2021-11-22 | Sell | 2,684 | $2.62 | $7,032 | 23,041 |
| RMED | 2020-08-03 | Buy | 10,000 | $0.35 | $3,500 | 50,202 |
| RMED | 2020-05-22 | Buy | 10,000 | $0.46 | $4,600 | 40,202 |
1 of 3 issuers are covered and open a security page; the rest are on file here only.
